Tag Archives: CTPB

‘HATs On’: A small molecule with big potential in epigenetic therapy for Parkinson’s disease

Parkinson’s disease (PD) is a common, progressive and age-related neurodegenerative disease, whose incidence is set to double by 2030 as people are living longer. At present, it is estimated that ten million people worldwide suffer with PD.